{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:39:02Z","timestamp":1786372742644,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2016,12]]},"abstract":"\n Background and objectives<\/jats:title>\n Supraventricular arrhythmias are associated with high morbidity and mortality. Nevertheless, this condition has received little attention in patients on hemodialysis. The objective of this study was to analyze the incidence of intradialysis supraventricular arrhythmia and its long\u2013term prognostic value.<\/jats:p>\n <\/jats:sec>\n \n Design, setting, participants, & measurements<\/jats:title>\n We designed an observational and prospective study in a cohort of patients on hemodialysis with a 10-year follow-up period. All patients were recruited for study participation and were not recruited for clinical indications. The study population comprised 77 patients (42 men and 35 women; mean age =58\u00b115 years old) with sinus rhythm monitored using a Holter electrocardiogram over six consecutive hemodialysis sessions at recruitment.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Hypertension was present in 68.8% of patients, and diabetes was present in 29.9% of patients. Supraventricular arrhythmias were recorded in 38 patients (49.3%); all of these were short, asymptomatic, and self-limiting. Age (hazard ratio, 1.04 per year; 95% confidence interval, 1.00 to 1.08) and right atrial enlargement (hazard ratio, 4.29; 95% confidence interval, 1.30 to 14.09) were associated with supraventricular arrhythmia in the multivariate analysis. During a median follow-up of 40 months, 57 patients died, and cardiovascular disease was the main cause of death (52.6%). The variables associated with all-cause mortality in the Cox model were age (hazard ratio, 1.04 per year; 95% confidence interval, 1.00 to 1.08), C-reactive protein (hazard ratio, 1.04 per 1 mg\/L; 95% confidence interval, 1.00 to 1.08), and supraventricular arrhythmia (hazard ratio, 3.21; 95% confidence interval, 1.29 to 7.96). Patients with supraventricular arrhythmia also had a higher risk of nonfatal cardiovascular events (hazard ratio, 4.32; 95% confidence interval, 2.11 to 8.83) and symptomatic atrial fibrillation during follow-up (hazard ratio, 17.19; 95% confidence interval, 2.03 to 145.15).<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The incidence of intradialysis supraventricular arrhythmia was high in our hemodialysis study population. Supraventricular arrhythmias were short, asymptomatic, and self-limiting, and although silent, these arrhythmias were independently associated with mortality and cardiovascular events.<\/jats:p>\n <\/jats:sec>","DOI":"10.2215\/cjn.04310416","type":"journal-article","created":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T22:48:43Z","timestamp":1475534923000},"page":"2210-2217","source":"Crossref","is-referenced-by-count":21,"title":["Asymptomatic Intradialytic Supraventricular Arrhythmias and Adverse Outcomes in Patients on Hemodialysis"],"prefix":"10.2215","volume":"11","author":[{"given":"Eduardo","family":"Verde","sequence":"first","affiliation":[{"name":"Department of Nephrology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"P\u00e9rez de Prado","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hospital de Le\u00f3n, Le\u00f3n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"L\u00f3pez-G\u00f3mez","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"Quiroga","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Goicoechea","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Garc\u00eda-Prieto","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Torres","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Reque","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Lu\u00f1o","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital General Universitario Gregorio Mara\u00f1\u00f3n, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2016,10,3]]},"reference":[{"key":"B1-20230813","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(14)60384-6","article-title":"Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure.","volume":"383","author":"Ortiz","year":"2014","journal-title":"Lancet"},{"issue":"Suppl 1","key":"B2-20230813","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.2215\/CJN.01960309","article-title":"Cardiovascular problems on hemodialysis: Current deficits and potential improvement.","volume":"4","author":"Ritz","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl","key":"B3-20230813","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2013.11.001","article-title":"US Renal Data System 2013 Annual Data Report.","volume":"63","author":"Collins","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B4-20230813","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2215\/CJN.09350915","article-title":"Arrhythmia and sudden death in hemodialysis patients: Protocol and baseline characteristics of the monitoring in dialysis study.","volume":"11","author":"Charytan","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2010050459","article-title":"The increasing prevalence of atrial fibrillation among hemodialysis patients.","volume":"22","author":"Winkelmayer","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.ajkd.2005.07.044","article-title":"Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients.","volume":"46","author":"Genovesi","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/ki.2009.477","article-title":"Atrial fibrillation in hemodialysis patients: Clinical features and associations with anticoagulant therapy.","volume":"77","author":"Wizemann","year":"2010","journal-title":"Kidney Int"},{"key":"B8-20230813","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/ki.2014.393","article-title":"Incidence and risk factors for new-onset atrial fibrillation among patients with end-stage renal disease undergoing renal replacement therapy.","volume":"87","author":"Liao","year":"2015","journal-title":"Kidney Int"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1161\/CIRCULATIONAHA.111.020982","article-title":"Chronic kidney disease is associated with the incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study.","volume":"123","author":"Alonso","year":"2011","journal-title":"Circulation"},{"key":"B11-20230813","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/europace\/euq042","article-title":"Alterations of atrial electrophysiology induced by electrolyte variations: Combined computational and P-wave analysis.","volume":"12","author":"Severi","year":"2010","journal-title":"Europace"},{"key":"B13-20230813","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1093\/ndt\/gfs416","article-title":"Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis.","volume":"27","author":"Zimmerman","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B14-20230813","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: The Framingham Heart Study.","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"key":"B15-20230813","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ki.2009.185","article-title":"Atrial fibrillation in incident dialysis patients.","volume":"76","author":"Vazquez","year":"2009","journal-title":"Kidney Int"},{"key":"B16-20230813","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/ndt\/gfu334","article-title":"Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation.","volume":"30","author":"Genovesi","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"B17-20230813","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","article-title":"Atrial fibrillation in patients with cryptogenic stroke.","volume":"370","author":"Gladstone","year":"2014","journal-title":"N Engl J Med"},{"key":"B18-20230813","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","article-title":"Cryptogenic stroke and underlying atrial fibrillation.","volume":"370","author":"Sanna","year":"2014","journal-title":"N Engl J Med"},{"key":"B19-20230813","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/105294199277860","article-title":"The International Conference on Harmonization Good Clinical Practice guideline.","volume":"6","author":"Dixon","year":"1998","journal-title":"Qual Assur"},{"key":"B20-20230813","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1161\/01.CIR.0000091380.04100.84","article-title":"ACC\/AHA\/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias).","volume":"108","author":"Blomstr\u00f6m-Lundqvist","year":"2003","journal-title":"Circulation"},{"key":"B21-20230813","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1161\/01.CIR.0000073597.57414.A9","article-title":"ACC\/AHA\/ASE 2003 guideline update for the clinical application of echocardiography: Summary article: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (ACC\/AHA\/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography).","volume":"108","author":"Cheitlin","year":"2003","journal-title":"Circulation"},{"key":"B22-20230813","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: A report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"B23-20230813","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation.","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"B24-20230813","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.109.874982","article-title":"Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke.","volume":"121","author":"Binici","year":"2010","journal-title":"Circulation"},{"key":"B25-20230813","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/europace\/eut346","article-title":"Recurrent intradialytic paroxysmal atrial fibrillation: Hypotheses on onset mechanisms based on clinical data and computational analysis.","volume":"16","author":"Vincenti","year":"2014","journal-title":"Europace"},{"key":"B26-20230813","first-page":"193","article-title":"[Natural history and outcomes of atrial fibrillation]","volume":"63","author":"Brigadeau","year":"2013","journal-title":"Rev Prat"},{"key":"B27-20230813","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"B28-20230813","first-page":"8","article-title":"The prevalence and predictors of atrial fibrillation in hemodialysis patients.","volume":"38","author":"Acar","year":"2010","journal-title":"Turk Kardiyol Dern Ars"},{"key":"B29-20230813","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijcard.2004.12.048","article-title":"Frequency of atrial fibrillation and factors related to its development in dialysis patients.","volume":"106","author":"Atar","year":"2006","journal-title":"Int J Cardiol"},{"key":"B31-20230813","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cjca.2014.10.009","article-title":"Right atrial volume is superior to left atrial volume for prediction of atrial fibrillation recurrence after direct current cardioversion.","volume":"31","author":"Luong","year":"2015","journal-title":"Can J Cardiol"},{"key":"B32-20230813","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1161\/CIRCIMAGING.110.962761","article-title":"Association between left and right atrial remodeling with atrial fibrillation recurrence after pulmonary vein catheter ablation in patients with paroxysmal atrial fibrillation: A pilot study.","volume":"4","author":"Akutsu","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"B33-20230813","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/ndt\/16.5.1090","article-title":"Serum potassium levels and atrial fibrillation in haemodialysis patients.","volume":"16","author":"Korzets","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"B34-20230813","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1016\/j.ijcard.2013.08.048","article-title":"Serum potassium levels and the risk of atrial fibrillation: The Rotterdam Study.","volume":"168","author":"Krijthe","year":"2013","journal-title":"Int J Cardiol"},{"key":"B35-20230813","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000329118","article-title":"Clinical characteristics and cardiovascular outcomes of hemodialysis patients with atrial fibrillation: A prospective follow-up study.","volume":"34","author":"Fujii","year":"2011","journal-title":"Am J Nephrol"},{"key":"B36-20230813","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/ndt\/gfp104","article-title":"Sudden death and associated factors in a historical cohort of chronic haemodialysis patients.","volume":"24","author":"Genovesi","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B37-20230813","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/2013.jamainternmed.744","article-title":"Atrial fibrillation and the risk of sudden cardiac death: The atherosclerosis risk in communities study and cardiovascular health study.","volume":"173","author":"Chen","year":"2013","journal-title":"JAMA Intern Med"},{"key":"B38-20230813","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0002-9149(84)90022-5","article-title":"Facilitation of ventricular tachycardia induction with abrupt changes in ventricular cycle length.","volume":"53","author":"Denker","year":"1984","journal-title":"Am J Cardiol"},{"key":"B39-20230813","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1001\/jama.2011.659","article-title":"Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation.","volume":"305","author":"Conen","year":"2011","journal-title":"JAMA"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201612000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:37:34Z","timestamp":1786369054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201612000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,3]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.04310416","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,3]]}}}